04/05/2018

For both 2017 FATCA and CRS reports, the reporting deadline set by the Administration des Contributions Directes (the « ACD ») is 30 June 2018.

As last year, the ACD is expecting a NIL FATCA report from each Foreign Financial Institution registered with the IRS. In contrast, only the non-NIL CRS reports are expected from the Luxembourg Financial Institutions.

Compared to last year, the reporting scope for CRS includes all types of accounts. In addition, the ACD enhanced the requirements related to the Tax Identification Number(s) of reportable accounts. Other reporting details are kept unchanged.

Should you require any assistance for the production or filing of such reports, do not hesitate to contact our experts at CRS-FATCA@arendt.com.

YOU MIGHT ALSO WANT TO DISCOVER

11/01/2021
Arendt Case Review #10 - January 2021 - Arendt Litigation Group

Information about recent decisions of the Luxembourg and/or European courts.

Read More_
Arendt We Live - Digitalisation and cybersecurity, an unhappy marriage or an essential partnership?






11/01/2021

Arendt Case Review #10 - January 2021 - Arendt Litigation Group

Information about recent decisions of the Luxembourg and/or European courts.
08/01/2021

Overview of the VAT impacts of Brexit

With the end of the transition period as of 1 January 2021, the UK officially became a third country with respect to the EU, meaning that the EU VAT D...
06/01/2021

International sanctions: a dedicated regime for financial sanction in Luxembourg

On December 23, 2020 the Luxembourg legislator has published the Law of 19 December 2020 implementing financial restrictive measures (“Law of 19 Decem...
30/12/2021

Changes as of 1 January 2021: increase of the minimum wage and provision of financial assi...

increase of the minimum wage and provision of financial assistance to companies
28/12/2021

OECD releases helpful new guidance on transfer pricing during the pandemic

On 18 December 2020, the OECD published its much-anticipated “Guidance on the Transfer Pricing Implications of the COVID-19 Pandemic”.